Growing Leadership Team Recent appointments of experienced board members like Mark Monaghan, with over 32 years in finance, indicate a strategic focus on strengthening corporate governance and attracting investment, presenting opportunities to offer investor relations and financial services.

Niche Market Focus Wesana's specialization in psychedelic medicine for mental health positions it within a rapidly expanding and innovative healthcare segment, suggesting potential for partnerships with mental health clinics, research institutions, and complementary biotech firms.

Funding and Revenue Gaps With minimal revenue between zero and one million dollars and a recent funding influx of 13 million dollars, there is an evident need for commercial development, sales of therapies, or technology solutions to accelerate revenue growth.

Industry Milestones Progress in drug development milestones and pipeline advancements, such as patent allowances and clinical milestones, highlight opportunities to collaborate with pharmaceutical developers, regulatory consultants, and clinical trial organizations.

Technological Infrastructure Utilizing cloud-based services like Google Cloud and a robust tech stack indicates a potential openness to digital health platform integrations, telemedicine solutions, and data management tools for mental health treatments.